Functions of natural killer cells

Nature Immunology

Volumn 9, Issue 5, 2008, Pages 503-510

  Vivier, Eric ^a,b,c,d   Tomasello, Elena ^a,b,c   Baratin, Myriam ^a,b,c   Walzer, Thierry ^a,b,c   Ugolini, Sophie ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD27 ANTIGEN; CD56 ANTIGEN; CELL SURFACE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR GAMMA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE GRANULOCYTIC LEUKEMIA; ADAPTIVE IMMUNITY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CELL INTERACTION; CELL MANIPULATION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DENDRITIC CELL; DISEASE CONTROL; ENDOTHELIUM CELL; HEPATITIS B; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATORY DISEASE; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MACROPHAGE; MALARIA FALCIPARUM; MEDICAL RESEARCH; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE; TARGET CELL;

ANIMALS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; ENDOTHELIAL CELLS; HOST VS GRAFT REACTION; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; INFLAMMATION; KILLER CELLS, NATURAL; MACROPHAGES; NEOPLASMS; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 42449151214     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1582     Document Type: Review

References (109)

1. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 47, 187-376 (1989).
2. Vivier, E., Nunes, J.A. & Vely, F. Natural killer cell signaling pathways. Science 306, 1517-1519 (2004).
3. Lanier, L.L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
4. Sivori S. et al. CpG and double-stranded RNA trigger human NK cells by Toll-like recepiors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA 101, 10116-10121 (2004).
5. Gerosa, F. et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174, 727-734 (2005).
6. Hart, O.M., Athie-Morales, V., O'Connor, G.M. & Gardiner, C.M. TLR7/ 8-mediated activation of human NK cells results in accessory cell-dependent IFN-γ production. J. Immunol. 175, 1636-1642 (2005).
7. Yokoyama, W.M., & Plougastel, B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3, 304-316 (2003).
8. Parham, P. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5, 201-214 (2005).
9. Kärre, K., Ljunggren, H.G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678 (1986).
10. Kumar, V. & McNerney, M.E. A new self:MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5, 363-374 (2005).
11. Gregoire, C. et al. The trafficking of natural killer cells. Immunol. Rev. 220, 169-182 (2007).
12. Zhang, Y. et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121, 258-265 (2007).
13. Jamieson, A.M., Isnard, P., Dorfman, J.R., Coles, M.C. & Raulet, D.H. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172, 864-870 (2004).
14. Walzer, T. et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 104, 3384-3389 (2007).
15. Hayakawa, Y. & Smyth, M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176, 1517-1524 (2006).
16. Kim, S. et al. In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 3, 523-528 (2002).
17. Cooper, M.A., Fehniger, T.A. & Caligiuri, M.A. The biology of human natural killer-cell subsets. Trends Immunol. 22, 633-640 (2001).
18. Anfossi, N. et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331-342 (2006).
19. Ferlazzo, G. & Munz, C. NK cell compartments and their activation by dendritic cells. J. Immunol. 172, 1333-1339 (2004).
20. Freud, A.G. & Caligiuri, M.A. Human natural killer cell development. Immunol. Rev. 214, 56-72 (2006).
21. Chen, S., Kawashima, H., Lowe, J.B., Lanier, L.L. & Fukuda, M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J. Exp. Med. 202, 1679-1689 (2005).
22. Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol. 8, 1337-1344 (2007).
23. - NK cells and late stage lymphoid progenitors. Cell. Immunol. 193, 226-235 (1999).
24. Parolini, S. et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109 3625-3632 (2007).
25. Long, E.O. Ready for prime time: NK cell priming by dendritic cells. Immunity 26, 385-387 (2007).
26. Walzer, T., Dalod, M., Robbins, S.H., Zitvogel, L. & Vivier, E. Natural-killer cells and dendritic cells: "I'union fait la force." Blood 106, 2252-2258 (2005).
27. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 101, 3052-3057 (2003).
28. Shanker, A. et al. CD8 T cell help for innate antitumor immunity. J. Immunol. 179, 6651-6662 (2007).
29. Laouar, Y., Sutterwala, F.S., Gorelik, L. & Flavell, R.A. Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nat. Immunol. 6, 600-607 (2005).
30. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med. 202, 1075-1085 (2005).
31. + T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J. Immunol. 176, 1582-1587 (2006).
32. Fehniger, T.A. et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811 (2007).
33. Bryceson, Y.T., March, M. E., Ljunggren, H.G. & Long, E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107, 159-166 (2006).
34. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503-517 (2007).
35. Johansson, M.H., Bieberich, C., Jay, G., Karre, K. & Hoglund, P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J. Exp. Med. 186 353-364 (1997).
36. Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713 (2005).
37. Yu, J. et al. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol. 179, 5977-5989 (2007).
38. Fernandez, N.C. et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416-4423 (2005).
39. Raulet, D.H. & Vance, R.E. Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6, 520-531 (2006).
40. Stewart, C.A. & Vivier, E. Strategies of NK cell recognition and their roles in tumor immunosurveillance. in How the Immune System Recognizes Self and Nonself: Immunoreceptors and Their Signaling (ed. Kitamura, D.) 37-81 (Springer, Tokyo, 2007).
41. Diefenbach, A., Jensen, E.R., Jamieson, A.M. & Raulet, D.H. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413, 165-171 (2001).
42. Cerwenka, A., Baron, J.L. & Lanier, L.L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 98, 11521-11526 (2001).
43. Kelly, J.M. et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3, 83-90 (2002).
44. Smyth, M.J. et al. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202, 583-588 (2005).
45. Street, S.E. et al. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells. J. Exp. Med. 199, 879-884 (2004).
46. Orange, J.S. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6, 399-409 (2006).
47. Imai, K., Matsuyama, S., Miyake, S., Suga, K. & Nakachi, K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of ageneral population. Lancet 356 1795-1799 (2000).
48. Ruggeri, L., Aversa, F., Martelli, M.F. & Velardi, A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol. Rev. 214, 202-218 (2006).
49. Bignon, J.D. & Gagne, K. KIR matching in hematopoietic stem cell transplantation. Curr. Opin. Immunol. 17, 553-559 (2005).
50. Koh, C.Y. et al. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. Blood 97, 3132-3137 (2001).
51. Ljunggren, H.G. & Malmherg, K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7, 329-339 (2007).
52. McKenna, D.H. Jr. et al. Good manufacturing practices production of natural killer cells for immunotherapy: A six-year single-institution experience. Transfusion 47, 520-528 (2007).
53. Miller, J.S. et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105, 3051-3057 (2005).
54. Lee, S.H., Miyagi, T. & Biron, C.A. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28, 252-259 (2007).
55. Scalzo, A.A., Corbett, A.J., Rawlinson, W.D., Scott, G.M. & Degli-Esposti, M.A. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol. Cell Biol. 85, 46-54 (2007).
56. Smith, H.R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99, 8826-8831 (2002).
57. Arase, H., Mocarski, E.S., Campbell, A.E., Hill, A.B. & Lanier, L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002).
58. Desrosiers, M.-P. et al. Epistasis between mouse Klra and major histocompatibility complex class'l loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37, 593-599 (2005).
59. Dalod, M. et al. Interferon α/β and interleukin 12 responses to viral infections: Pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517-528 (2002).
60. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P. & Salazar-Mather, T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 (1999).
61. Vidal, S.M. & Lanier, L.L. NK cell recognition of mouse cytomegalovirus-infected cells. Curr. Top. Microbiol. Immunol. 298, 183-206 (2006).
62. Voigt, S. et al. Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1:OCil/Clr-b missing-self axis. Immunity 26, 617-627 (2007).
63. Fischer, A. Human primary immunodeficiency diseases. Immunity 27, 835-845 (2007).
64. Raulet, D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5, 996-1002 (2004).
65. Paya, C.V., Patick, A.K., Leibson, P.J. & Rodriguez, M. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143, 95-102 (1989).
66. Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M. & Rose, N.R. From infection to autoimmunity. J. Autoimmun. 16, 175-186 (2001).
67. Robbins, S.H. et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3, e123 (2007).
68. van Dommelen, S.L.H. et al. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25 835-848 (2006).
69. Janka, G.E. Hemophagocytic syndromes. Blood Rev. 21, 245-253(2007).
70. + Tcells and interferon gamma are essential for the disorder. Blood 104, 735-743 (2004).
71. Crozat, K. et al. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: A: mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J. Exp. Med. 204, 853-863 (2007).
72. Nedvetzki, S. et al. Redprocal regulation of natural killer cells and macrophages associated with distiact immune synapses. Blood 109, 3776-3785 (2007).
73. Moretta, L. et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev. 214, 219-228 (2006).
74. Degli-Esposti, M.A. & Smyth, M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5, 112-124 (2005).
75. Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335-341 (2002).
76. Hayakawa, Y. et al. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172, 123-129 (2004).
77. Yu, G., Xu, X., Vu, M.D., Kilpatrick, E.D. & Li, X.C. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med. 203, 1851-1858 (2006).
78. Wu, H.J. et al. Inflammatory arthritis can be reined in by CpG-induced DC NK cell cross talk. J. Exp. Med. 204, 1911-1922 (2007).
79. H1 priming. Nat. Immunol. 5 1260-1265 (2004).
80. Morandi, B., Bougras, G., Muller, W.A., Ferlazzo, G. & Munz, C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-γ secretion. Eur. J. Immunol. 36, 2394-2400 (2006).
81. + T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26, 593-604 (2007).
82. Takeda, K. & Dennert, G. The development of autoimmunity in C57BL/6 Ipr mice correlates with the disappearance of natural killer type 1-positive cells: Evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exo. Med. 177, 155-164 (1993).
83. Johansson, S., Berg, L., Hall, H. & Hoglund, P. NK cells: Elusive players in autoimmunity. Trends Immunol. 26, 613-618 (2005).
84. Yoneda, O. et al. Fractalkine-mediated enclothelial cell injury by NK cells. J. Immunol. 164, 4055-4062 (2000).
85. Bolovan-Fritts, C.A. & Spector, S.A. Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood 111, 175-182 (2008).
86. 1, complement and NK cells team up to activate and destroy the enclothelium. Trends Immunol. 26, 2-5 (2005).
87. Anne Croy, B., van den Heuvel, M.J., Borzychowski, A.M. & Tayade, C. Uterine natural killer cells: A specialized differentiation regulated by ovarian hormones. Immunol. Rev. 214, 161-185 (2006).
88. Hanna, J. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12 1065-1074 (2006).
89. Moffett, A. & Hiby, S.E. How does the maternal immune system contribute to the development of pre-eclampsia? Placenta 28 (suppl. A), S51-S56 (2007).
90. Dunn, C. et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204, 667-680 (2007).
91. Chen, Y. et al. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46, 706-715 (2007).
92. Kerr, A.R. et al. Identification of a detrimental role for NK cells in pneumoccal pneumonia and sepsis in immunocompromised hosts. Microbes Infect. 7, 845-852 (2005).
93. Badgwell, B. et al. Natural killercells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 132, 205-212 (2002).
94. Flodstrom, M. et al. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3, 373-382 (2002).
95. Poirot, L., Benoist, C. & Mathis, D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl. Acad. Sci. USA 101, 8102-8107 (2004).
96. de Matos, C.T. et al. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: Role of CD94/ NKG2A in control of cytokine secretion. Immunology 122, 291-301 (2007).
97. Katchar, K., Soderstrom, K., Wahlstrom, J., Eklund, A. & Grunewald, J. Characterisation of natural killer cells and CD56+ T-cells in sarcoicoidosis patients. Eur. Respir. J. 26, 77-85 (2005).
98. O'Leary, J.G., Goodarzi, M., Drayton, D.L. & von Andrian, U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7, 507-516 (2006).
99. Lambiase, A. et al. Natural killer cells in vernal keratoconjunctivitis. Mol. Vis. 13, 1562-1567 (2007).
100. Buentke, E. et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin - Malassezia-influenced cell interaction. J. Invest. Dermatol. 119, 850-857 (2002).
101. - NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur. J. Immunol. 36, 118-128 (2006).
102. Tagliabue, A., Befus, A.D., Clark, D.A. & Bienenstock, J. Characteristics of natural killer cells in the murine intestinaf epithelium and lamina propria. J. Exp. Med. 155, 1785-1796 (1982).
103. Korbel, D.S., Finney, O.C. & Riley, E.M. Natural killer cells and innate immunity to protozoan pathogens. Int. J. Parasitol. 34, 1517-1528 (2004).
104. Roetynck, S. et al. Natural killer cells and malaria. Immunol. Rev. 214, 251-263 (2006).
105. + natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 102, 2886-2891 (2005).
106. Alter, G. et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KJR/HLA subtypes. J. Exp. Med. 204, 3027-3036 (2007).
107. Carr, W.H. et al. Cutting edge. KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178, 647-651 (2007).
108. Vieillard. V., Strominger, J.L. & Debre. P. NK cytotoxicity against CD4- T cells during HIV-1 infection: A gp4l peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. USA 102, 10981-10986 (2005).
109. Kim, S., Iizuka, K., Aguila, H.L., Weissman, I.L. & Yokoyama, W.M. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc. Natl. Acad. Sci. USA 97, 2731-2736 (2000).